247 related articles for article (PubMed ID: 25231155)
1. Rare platelet GPCR variants: what can we learn?
Nisar SP; Jones ML; Cunningham MR; Mumford AD; Mundell SJ;
Br J Pharmacol; 2015 Jul; 172(13):3242-53. PubMed ID: 25231155
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological consequences of receptor mistraffic: Tales from the platelet P2Y
Cunningham MR; Aungraheeta R; Mundell SJ
Mol Cell Endocrinol; 2017 Jul; 449():74-81. PubMed ID: 28212842
[TBL] [Abstract][Full Text] [Related]
3. Targeting platelet G-protein coupled receptors (GPCRs): looking beyond conventional GPCR antagonism.
Dowal L; Flaumenhaft R
Curr Vasc Pharmacol; 2010 Mar; 8(2):140-54. PubMed ID: 19485898
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
Gurbel PA; Kuliopulos A; Tantry US
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
[TBL] [Abstract][Full Text] [Related]
5. Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.
Chaudhary PK; Kim S; Jee Y; Lee SH; Park KM; Kim S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486261
[TBL] [Abstract][Full Text] [Related]
6. Diversity and impact of rare variants in genes encoding the platelet G protein-coupled receptors.
Jones ML; Norman JE; Morgan NV; Mundell SJ; Lordkipanidzé M; Lowe GC; Daly ME; Simpson MA; Drake S; Watson SP; Mumford AD;
Thromb Haemost; 2015 Apr; 113(4):826-37. PubMed ID: 25567036
[TBL] [Abstract][Full Text] [Related]
7. TBXA2R gene variants associated with bleeding.
Mundell SJ; Mumford A
Platelets; 2018 Nov; 29(7):739-742. PubMed ID: 30089223
[TBL] [Abstract][Full Text] [Related]
8. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.
Spath B; Hansen A; Bokemeyer C; Langer F
Platelets; 2012; 23(1):60-8. PubMed ID: 21736422
[TBL] [Abstract][Full Text] [Related]
9. The Roles of GRKs in Hemostasis and Thrombosis.
Chen X; Zhao X; Cooper M; Ma P
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731360
[TBL] [Abstract][Full Text] [Related]
10. Low multiple electrode aggregometry platelet responses are not associated with non-synonymous variants in G-protein coupled receptor genes.
Norman JE; Lee KR; Walker ME; Murden SL; Harris J; Mundell S; J Murphy G; Mumford AD
Thromb Res; 2015 Oct; 136(4):818-24. PubMed ID: 26297398
[TBL] [Abstract][Full Text] [Related]
11. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
[TBL] [Abstract][Full Text] [Related]
12. A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction.
Nisar SP; Lordkipanidzé M; Jones ML; Dawood B; Murden S; Cunningham MR; Mumford AD; Wilde JT; Watson SP; Mundell SJ; Lowe GC;
Thromb Haemost; 2014 May; 111(5):923-32. PubMed ID: 24452735
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
Coccheri S
Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.
Kalantzi KI; Tsoumani ME; Goudevenos IA; Tselepis AD
Expert Rev Clin Pharmacol; 2012 May; 5(3):319-36. PubMed ID: 22697594
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
[TBL] [Abstract][Full Text] [Related]
16. Regulators of platelet cAMP levels: clinical and therapeutic implications.
Noé L; Peeters K; Izzi B; Van Geet C; Freson K
Curr Med Chem; 2010; 17(26):2897-905. PubMed ID: 20858171
[TBL] [Abstract][Full Text] [Related]
17. Anti-platelet and anti-thrombotic effect of a traditional herbal medicine Kyung-Ok-Ko.
Kim TH; Lee KM; Hong ND; Jung YS
J Ethnopharmacol; 2016 Feb; 178():172-9. PubMed ID: 26657497
[TBL] [Abstract][Full Text] [Related]
18. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
Nurden AT
Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
[TBL] [Abstract][Full Text] [Related]
19. Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy.
Knowles RB; Warner TD
Pharmacol Ther; 2019 Jan; 193():83-90. PubMed ID: 30081048
[TBL] [Abstract][Full Text] [Related]
20. Response variability to P2Y12 receptor inhibitors: expectations and reality.
Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
